secwatch / observer
AXIM AXIM BIOTECHNOLOGIES, INC.
CIK 0001514946 3 ready 8-Ks latest October 15, 2024, 7:59 PM ET RSS · JSON
Ready 8-Ks 3
Latest filing October 15, 2024, 7:59 PM ET
Top materiality 0.80
Event mix other_material ×1 · debt ×1 · litigation ×1
Sentiment 0 pos · 1 neg · 2 neu
Executive change recent →

Recent 8-K filings for AXIM

Executive changes

Appointed

Catalina Valencia

Series C Director
AXIM · AXIM BIOTECHNOLOGIES, INC.
Effective
2024-10-14
Filed
October 15, 2024, 7:59 PM ET
effective October 14, 2024, Juniper, the record holder of all 500,000 shares of Series C Preferred Stock issued and outstanding, which shares are exclusively entitled to fill any vacancy of a Series C Director seat, appointed Catalina Valencia to fill the Series C Director vacancy
Departed

John W. Huemoeller II

President and CEO
AXIM · AXIM BIOTECHNOLOGIES, INC.
Effective
2024-10-09
Successor
Catalina Valencia
Filed
October 15, 2024, 7:59 PM ET
Due to the fact that the Company's President and CEO, John W. Huemoeller II, was unable to serve as an officer of the Company as a result of serious illness
Departed

John W. Huemoeller II

Series C Director
AXIM · AXIM BIOTECHNOLOGIES, INC.
Effective
2024-10-12
Successor
Catalina Valencia
Filed
October 15, 2024, 7:59 PM ET
On October 12, 2024, President and Series C Director, John W. Huemoeller II died as a result of his illness.
Appointed

Catalina Valencia

President
AXIM · AXIM BIOTECHNOLOGIES, INC.
Effective
2024-10-09
Filed
October 15, 2024, 7:59 PM ET
on October 9, 2024, the Company’s board of directors appointed Catalina Valencia as the Company’s new President.

Materiality & sentiment trend

Max materiality 0.80 · Median 0.60 · Most common event other_material

0 positive 1 negative 2 neutral

source · AXIM on sec.gov